Seattle Children’s Hospital

Date of Award

07.12.2023

Program

Prevent & Delay

Amount

$1,828,307.00

Term of Grant

36 months

Project Title

Expanding Use of Engineered Tregs in T1D Therapy (Phase 4)

Project Description

Funds to support preclinical studies to develop a new targeted immunotherapy for type 1 diabetes.